| 1 |
34776443 | Patterns of Distribution of 18F-THK5351 Positron Emission Tomography in Alzheimer's Disease Continuum. | 2022 |
2 |
| 2 |
35210989 | Imaging of Reactive Astrogliosis by Positron Emission Tomography. | 2022 |
1 |
| 3 |
34305778 | Recurrent Lobar Hemorrhages and Multiple Cortical Superficial Siderosis in a Patient of Alzheimer's Disease With Homozygous APOE ε2 Allele Presenting Hypobetalipoproteinemia and Pathological Findings of 18F-THK5351 Positron Emission Tomography: A Case Report. | 2021 |
2 |
| 4 |
34912209 | 18F-THK5351 Positron Emission Tomography Imaging in Neurodegenerative Tauopathies. | 2021 |
4 |
| 5 |
32657863 | 18F-THK5351 PET Can Identify Lesions of Acute Traumatic Brain Injury. | 2020 Nov |
1 |
| 6 |
31464590 | THK5351 and flortaucipir PET with pathological correlation in a Creutzfeldt-Jakob disease patient: a case report. | 2019 Aug 29 |
3 |
| 7 |
31795034 | Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [18F]THK5351 uptake in progressive supranuclear palsy. | 2019 |
4 |
| 8 |
28864633 | Correlations of 18F-THK5351 PET with Postmortem Burden of Tau and Astrogliosis in Alzheimer Disease. | 2018 Apr |
1 |
| 9 |
29958546 | Neuroimaging-pathological correlations of [18F]THK5351 PET in progressive supranuclear palsy. | 2018 Jun 29 |
4 |
| 10 |
28359327 | Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain. | 2017 Mar 31 |
3 |